kr249.00
0.00%
Oslo, Sep 25, 04:17 pm CEST. Closed.
ISIN
NO0010159684
Symbol
MEDI

Medistim Target price 2026 - Analyst rating & recommendation

Medistim Classifications & Recommendation

Buy
88%
Hold
13%

Medistim Price Target

Target Price kr339.15
Price kr249.00
Potential
Number of Estimates 4
4 Analysts have issued a price target Medistim 2027 . The average Medistim target price is kr339.15. This is higher than the current stock price. The highest price target is , the lowest is .
A rating was issued by 8 analysts: 7 Analysts recommend Medistim to buy, 1 to hold and 0 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the Medistim stock has an average upside potential 2027 of . Most analysts recommend the Medistim stock at Purchase.

Sales and Margin forecast 2026, 2027 & 2028

Create a premium account to unlock analyst estimates. Learn more

Select at least one metric to display the chart.


Dec '25 2026
Estimates
Revenue Million kr 699.77 816.00
24.38% 16.61%
EBITDA Margin 31.58% 31.12%
14.21% 1.47%
Net Margin 22.75% 21.56%
23.28% 5.24%

3 Analysts have issued a sales forecast Medistim 2026 . The average Medistim sales estimate is

kr816m
unlock
. This is
48.05% higher
unlock
than the revenue of the last 12 months(TTM). The highest sales forecast is
kr840m 52.40%
unlock
, the lowest is
kr784m 42.24%
unlock
.

This results in the following potential growth metrics:

Revenue Estimates

2025 kr700m 24.38%
2026
kr816m 16.61%
unlock
2027
kr889m 9.00%
unlock
2028
kr969m 8.94%
unlock

3 Analysts have issued an Medistim EBITDA forecast 2026. The average Medistim EBITDA estimate is

kr254m
unlock
. This is
51.97% higher
unlock
than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is
kr261m 56.44%
unlock
, the lowest is
kr244m 46.01%
unlock
.

This results in the following potential growth metrics and future EBITDA Margins:

EBITDA Estimates

2025 kr221m 42.05%
2026
kr254m 14.91%
unlock
2027
kr262m 3.21%
unlock
2028
kr289m 10.12%
unlock

EBITDA Margin

2025 31.58% 14.21%
2026
31.12% 1.47%
unlock
2027
29.47% 5.30%
unlock
2028
29.79% 1.09%
unlock

3 Medistim Analysts have issued a net profit forecast 2026. The average Medistim net profit estimate is

kr176m
unlock
. This is
40.72% higher
unlock
than the net profit for the last 12 months(TTM). The highest net profit forecast is
kr181m 44.87%
unlock
, the lowest is
kr169m 35.21%
unlock
.

This results in the following potential growth metrics and future Net Margins:

Net Profit Estimates

2025 kr159m 53.34%
2026
kr176m 10.50%
unlock
2027
kr182m 3.29%
unlock
2028
kr203m 11.91%
unlock

Net Margin

2025 22.75% 23.28%
2026
21.56% 5.24%
unlock
2027
20.43% 5.24%
unlock
2028
20.99% 2.74%
unlock

Earnings per share, P/E ratio and EV/sales Estimates 2026, 2027 & 2028

Create a premium account to unlock analyst estimates. Learn more

Select at least one metric to display the chart.


Dec '25 2026
Estimates
Earnings Per Share kr 8.71 9.62
53.62% 10.45%
P/E 25.89
EV/Sales 5.39

3 Analysts have issued a Medistim forecast for earnings per share. The average Medistim EPS is

kr9.62
unlock
. This is
40.64% higher
unlock
than earnings per share in the financial year 2025. The highest EPS forecast is
kr9.90 44.74%
unlock
, the lowest is
kr9.24 35.09%
unlock
.

This results in the following potential growth metrics and future valuations:

Earnings Per Share

2025 kr8.71 53.62%
2026
kr9.62 10.45%
unlock
2027
kr9.93 3.22%
unlock
2028
kr11.12 11.98%
unlock

P/E ratio

Current 36.40 4.41%
2026
25.89 28.88%
unlock
2027
25.06 3.21%
unlock
2028
22.40 10.61%
unlock

Based on analysts' sales estimates for 2026, the Medistim stock is valued at an EV/Sales of

and an P/S ratio of .

This results in the following potential growth metrics and future valuations:

EV/Sales

Current 7.98 13.03%
2026
5.39 32.48%
unlock
2027
4.94 8.26%
unlock
2028
4.54 8.21%
unlock

P/S ratio

Current 8.10 12.82%
2026
5.47 32.45%
unlock
2027
5.02 8.26%
unlock
2028
4.61 8.21%
unlock

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today